We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
-1.22%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$877M
AUM Growth
-$34.1M
Cap. Flow
-$15.3M
Cap. Flow %
-1.75%
Top 10 Hldgs %
20.47%
Holding
269
New
8
Increased
55
Reduced
114
Closed
8

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$5.62M
2
TEL icon
TE Connectivity
TEL
+$2.05M
3
V icon
Visa
V
+$1.09M
4
CRM icon
Salesforce
CRM
+$683K
5
WELL icon
Welltower
WELL
+$661K

Sector Composition

Rank Sector Weight
1 Healthcare 16.6%
2 Technology 15.22%
3 Miscellaneous 13.85%
4 Industrials 12.99%
5 Financials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
51
Merck
MRK
$354B
$5.76M 0.66%
110,759
-1,760
-2% -$95.1K
PM icon
52
Philip Morris
PM
$301B
$5.72M 0.65%
57,543
+49
+0.1% +$5.1K
RTN
53
DELISTED
Raytheon Company
RTN
$5.63M 0.64%
26,076
-1,005
-4% -$208K
SRCL
54
DELISTED
Stericycle Inc
SRCL
$5.56M 0.63%
95,053
-3,362
-3% -$228K
GLNG icon
55
Golar LNG
GLNG
$5.19B
$5.55M 0.63%
202,841
-455
-0.2% -$12.8K
WY icon
56
Weyerhaeuser
WY
$15.9B
$5.48M 0.62%
156,468
-8,146
-5% -$287K
SPGI icon
57
S&P Global
SPGI
$122B
$5.46M 0.62%
28,580
-300
-1% -$55.4K
DHR icon
58
Danaher
DHR
$146B
$5.45M 0.62%
62,779
-242
-0.4% -$21.2K
WAB icon
59
Wabtec
WAB
$46.9B
$5.21M 0.59%
64,067
-4,450
-6% -$358K
THO icon
60
Thor Industries
THO
$3.75B
$5.14M 0.59%
44,674
-193
-0.4% -$25.8K
EEM icon
61
iShares MSCI Emerging Markets ETF
EEM
$30.6B
$5.01M 0.57%
103,682
TMO icon
62
Thermo Fisher Scientific
TMO
$235B
$4.95M 0.56%
23,973
-347
-1% -$72.8K
CVX icon
63
Chevron
CVX
$425B
$4.94M 0.56%
43,286
-1,805
-4% -$216K
JPM icon
64
JPMorgan Chase
JPM
$916B
$4.67M 0.53%
42,431
-1,927
-4% -$218K
INTC icon
65
Intel
INTC
$515B
$4.61M 0.53%
88,488
-9,871
-10% -$469K
GE icon
66
GE Aerospace
GE
$321B
$4.37M 0.5%
67,637
-6,683
-9% -$495K
KMI icon
67
Kinder Morgan
KMI
$68.6B
$4.33M 0.49%
287,696
-18,247
-6% -$316K
IDXX icon
68
Idexx Laboratories
IDXX
$40.2B
$4.23M 0.48%
22,094
+108
+0.5% +$19.9K
CSCO icon
69
Cisco
CSCO
$433B
$4.14M 0.47%
96,427
+2,000
+2% +$84.8K
PFE icon
70
Pfizer
PFE
$157B
$4.03M 0.46%
119,569
-211
-0.2% -$7.25K
LECO icon
71
Lincoln Electric
LECO
$13.8B
$4M 0.46%
44,504
+395
+0.9% +$36.8K
MO icon
72
Altria Group
MO
$117B
$4M 0.46%
64,134
+200
+0.3% +$13.2K
VEU icon
73
Vanguard FTSE All-World ex-US ETF
VEU
$69B
$3.88M 0.44%
71,384
+1,059
+2% +$59K
KO icon
74
Coca-Cola
KO
$381B
$3.72M 0.42%
85,588
-1,176
-1% -$52.8K
IBM icon
75
IBM
IBM
$236B
$3.71M 0.42%
25,298
-252
-1% -$38.1K

Similar funds

Boston Family Office's Q1 2018 Portfolio in Review

As of Q1 2018, Boston Family Office held 269 positions worth $877M, down 3.7% from $911M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Family Office's Q1 2018 filing shows 8 new, 55 increased, 114 reduced and 8 closed positions. Its largest new stake was CRISPR Therapeutics: 10,000 shares worth $457K. The largest sale was Straight Path Communications Inc., an estimated $5.37M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Technology and Miscellaneous.

  • Boston Family Office's largest Q1 2018 buy was CRISPR Therapeutics: 10,000 shares worth $457K.
  • Boston Family Office added most to Verizon in Q1 2018, an estimated $5.62M increase.
  • Boston Family Office's biggest Q1 2018 reduction was Ansys, cutting an estimated $3.27M.
  • Boston Family Office fully exited Straight Path Communications Inc. in Q1 2018, selling an estimated $5.37M.
  • Boston Family Office's ten largest holdings make up 20% of its $877M portfolio in Q1 2018.
  • Boston Family Office opened 8 new positions and closed 8 in Q1 2018.
  • Boston Family Office's portfolio value fell 3.7% quarter-over-quarter to $877M.

Based on Boston Family Office's 13F filing for Q1 2018, filed 30 Apr 2018.